GCV

(redirected from ganciclovir)
Also found in: Dictionary, Medical, Wikipedia.
Related to ganciclovir: Valganciclovir
AcronymDefinition
GCVGanciclovir
GCVGround Combat Vehicle (US Army)
GCVGeneralized Cross Validation
GCVGross Calorific Value
GCVGreat Cardiac Vein
GCVGewone Commanditaire Vennootschap (Dutch)
GCVGonsenheimer Carneval-Verein
GCVGross Caloric Value
GCVGreater Checkerboard Vault (gaming)
GCVCrystal-Vintage Growth (stock symbol)
GCVGene Combination Value
GCVGlobal Causality Violation (quantum physics)
GCVGoing Concern Value (finance)
References in periodicals archive ?
High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration.
Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients.
The combination of ART and intravitreal ganciclovir injections was given to 5 participants.
She developed pneumonia with ground-glass appearance on thorax computed tomography and CMV positivity recurred; ganciclovir was re-initiated.
The guidelines for ganciclovir use remain anecdotal.
Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
Siendo la serologia CMV donante positivo, receptora negativo, se inicia profilaxis con ganciclovir.
Initiation of antiviral therapy with valacyclovir, acyclovir, or ganciclovir may be warranted if the history and/or symptoms are compatible with B virus infection.
At this point, he was producing up to two litres of diarrhoea over a 24-hour period and intravenous ganciclovir 5 mg/kg 12 hourly was commenced.
Based on previous published data, the incidence of CMV is expected to be 12% in the oral ganciclovir arm of the study.
Results were negative, except for a temporarily weak reactivity for Aspergillus antigen in serum and for CMV DNA in peripheral blood lymphocytes, which was positive before and became negative after ganciclovir therapy.
The treatment consists of the injection of modified T-cells expressing TK followed by treatment with ganciclovir if graft versus host disease occurs.